glimepiride has been researched along with Arterial Diseases, Carotid in 7 studies
glimepiride: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to compare the effect of pioglitazone, an insulin sensitizer, with glimepiride, an insulin secretagogue, on atherosclerotic plaque inflammation by using serial (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging." | 9.15 | Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. ( Harada, H; Hayabuchi, N; Ikeda, H; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mawatari, K; Mizoguchi, M; Nitta, Y; Oba, T; Tahara, A; Tahara, N; Yamagishi, S; Yasukawa, H, 2011) |
| "The aim of this study was to compare the effect of pioglitazone, an insulin sensitizer, with glimepiride, an insulin secretagogue, on atherosclerotic plaque inflammation by using serial (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging." | 5.15 | Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. ( Harada, H; Hayabuchi, N; Ikeda, H; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mawatari, K; Mizoguchi, M; Nitta, Y; Oba, T; Tahara, A; Tahara, N; Yamagishi, S; Yasukawa, H, 2011) |
| "Pioglitazone treatment led to improvement in levels of multiple cardiovascular risk markers, including high-sensitivity C-reactive protein, apolipoprotein B, apolipoprotein A1, high-density lipoprotein (HDL) cholesterol, triglyceride, insulin, and free fatty acid." | 2.73 | Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus. ( Chen, Z; D'Agostino, R; Davidson, M; Feinstein, S; Haffner, S; Kondos, GT; Mazzone, T; Meyer, PM; Perez, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davidson, MH | 1 |
| Beam, CA | 1 |
| Haffner, S | 2 |
| Perez, A | 2 |
| D'Agostino, R | 2 |
| Mazzone, T | 2 |
| Katakami, N | 1 |
| Kaneto, H | 1 |
| Matsuhisa, M | 1 |
| Shimomura, I | 1 |
| Yamasaki, Y | 1 |
| Tawakol, A | 1 |
| Finn, AV | 1 |
| Mizoguchi, M | 1 |
| Tahara, N | 1 |
| Tahara, A | 1 |
| Nitta, Y | 1 |
| Kodama, N | 1 |
| Oba, T | 1 |
| Mawatari, K | 1 |
| Yasukawa, H | 1 |
| Kaida, H | 1 |
| Ishibashi, M | 1 |
| Hayabuchi, N | 1 |
| Harada, H | 1 |
| Ikeda, H | 1 |
| Yamagishi, S | 1 |
| Imaizumi, T | 1 |
| Marwick, TH | 1 |
| Narula, J | 1 |
| Matsumoto, K | 1 |
| Sera, Y | 1 |
| Abe, Y | 1 |
| Tominaga, T | 1 |
| Yeki, Y | 1 |
| Miyake, S | 1 |
| Davidson, M | 1 |
| Meyer, PM | 1 |
| Feinstein, S | 1 |
| Kondos, GT | 1 |
| Chen, Z | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Detection of Plaque Inflammation and Visualization of Anti-Inflammatory Effects of Pioglitazone on Plaque Inflammation in Subjects With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus by FDG-PET/CT[NCT00722631] | 70 participants (Actual) | Interventional | 2007-05-31 | Completed | |||
| A Double-Blind, Randomized, Comparator-Controlled Study in Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl Versus Glimepiride on the Rate of Progression of Atherosclerotic Disease as Measured by Carotid Intima-Media Thickn[NCT00225264] | Phase 3 | 458 participants (Actual) | Interventional | 2003-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for glimepiride and Arterial Diseases, Carotid
4 other studies available for glimepiride and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients.
Topics: Aged; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Ag | 2011 |
Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortic Diseases; Aortography; Atherosclerosis; Carotid Art | 2011 |
Imaging of pharmacologic intervention decoding therapeutic mechanism or defining effectiveness?
Topics: Anti-Inflammatory Agents; Aortic Diseases; Aortography; Carotid Artery Diseases; Diabetes Mellitus, | 2011 |
Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes.
Topics: Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Chronic Disease; Diabetes Mellitus, Typ | 2004 |